Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01788527 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
A NA study, sponsored by Mount Sinai Hospital, Canada.
- Completed
- Registry status
- NA
- Development phase
- 325
- Enrollment target
NCT01788527: Completed NA study, sponsored by Mount Sinai Hospital, Canada.
NCT01788527 is a NA study that has completed, run by Mount Sinai Hospital, Canada. The registered enrollment target is 325 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01788527, a NA study, has completed, sponsored by Mount Sinai Hospital, Canada.
- COMPLETED
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
Study Summary
The primary objective of the study is to determine if RT CGM (Real Time-Continuous Glucose Monitoring) can improve glycemic control in women with T1D who are pregnant or planning pregnancy.
Primary Outcome
Glycemic control as measured by HbA1c at 24 weeks or at conception. If the patient becomes pregnant, than a HbA1c will be measured post-confirmation of a positive pregnancy test and will contribute to the primary outcome.
Interventions
- DEVICE CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT01788527 record still lists
NCT01788527 is an interventional study that assigns participants to a tested intervention. The registered 325 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 1 intervention - of which CGM is the first listed.
NCT01788527 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01788527 about?
NCT01788527 is a clinical study titled "Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial". The primary objective of the study is to determine if RT CGM (Real Time-Continuous Glucose Monitoring) can improve glycemic control in women with T1D who are pregnant or planning pregnancy.
What is the current status of trial NCT01788527?
This trial is currently completed. It is a NA study. The enrollment target is 325 participants. The study started on 2013-03. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01788527?
The interventions under investigation include: CGM (DEVICE).
Who is sponsoring clinical trial NCT01788527?
This trial is sponsored by Mount Sinai Hospital, Canada, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01788527's enrollment target sits among peer trials
325 311th of 2000 higher than 1,689 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02543983 · 325 participants · Phase 2
Neurobiology of Suicide
- NCT03016819 · 325 participants · Phase 3
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
- NCT03288207 · 325 participants · NA
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
- NCT04986657 · 325 participants · NA
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia